You have successfully logged out.

Hello !
Logout

OncoSafety Remote Control®

Safety and traceability in onco-hematological treatment administration

Cancer is one of the leading causes of death worldwide. In addition, errors in the prescription, preparation and administration of cytostatic drugs can lead to severe consequences and harm to patients. Studies have shown that medication errors account for a significant percentage, if not the majority, of both total medical errors and medical misadventures resulting in mortality.1 Medication errors have particularly severe consequences in oncology.

Dr. Nicolas Jordi

“Validation of all process steps of prescribing, manufacturing and administration ensures "that we administer the right drug to the right patient in the right order, dosage and flow rate."”

Dr. Jordi Nicolás Picó, Head of Hospital Pharmacy at University Hospital Mútua Terrassa, Spain.
OncoSafety Remote Control®

OncoSafety Remote Control®

Safety and traceability in onco-hematological treatment administration

Read more

Read about Clara Pujol's experiences with OncoSafety Remote Control®

"It has become extremely difficult for us to make an error during the administration of chemotherapy."

Find out more

The 5-point scan process for chemotherapy treatments

Step 1

Scanning the patient’s wristband. The patient’s name and treatment are displayed on the PDA.

Step 2

Scanning the nurse ID batch. The full name of the person infusing the mixture is displayed on the PDA.

Step 3

Scanning the location. The therapy site where the patient is located is displayed on the PDA screen.

Step 4

Scanning the pump. The name of the infusion pump responsible for infusing the mixture is displayed. The information entered by the prescription system is transferred to the auto-programming port of the WiFi pump.

Step 5

Scanning the medication. The name of the chemotherapy drug and accompanying information are shown on the PDA.

Spaceplus Infusomat®

The Spaceplus Infusomat® offers the latest technology of high precision infusions in combination with our superior Infusomat® Space Lines for intravenous, epidural, parenteral and enteral applications.Advanced:+‐ 3% delivery accuracy in combination with Infusomat® Space LinesEfficient Freeflow protection with device and set‐based anti‐freeflow clampsCustomized operating user interface guidance – more convenience based on human factors testingIP44 moisture protection: Best in class protected against water splashed from all directionsLarge colour touch display: high resolution visible from all angles for safe operation and usable with wet glovesUsable as stand‐alone device with integrated WiFi, power supply and handle and compatible with the Spaceplus StationRemote Updates / Upgrades of Software and DrugLibraries at the point of care without influencing clinical workflowsDedicated Infusomat® Space Lines covering all therapy areas: infusion, pain, nutrition, blood, enteral, epidural, light‐protection, cytostaticsDigital:Cybersecurity: end‐to‐end data encryption fulfills high requirementsData communication towards EMR / PDMS systems via HL7 interface, Ethernet and WiFiSingle pump connectivity via WiFi, bedplace connectivity via Spaceplus DatamoduleDrug Library Manager establish customized drug data bases for different care units, patient profiles with individual drug colour codes and dosage limits

Infusomat® Space

The Infusomat® Space pump is the volumetric infusion pump solution to configure customized, tailor-made solutions as individual pumps, small therapy units, or a complex infusion system.The small, light and intuitive configuration of the pump provides a userfriendly solution to complex therapies, integrating all clinical areas into one system.The Infusomat® Space volumetric infusion pump system includes dedicated administration sets and pump accessories.B. Braun Space can also be integrated into the data communications network of every advanced hospital operation.

Cyto-Set® Infusion 

Single-use, sterile infusion system for the preparation and administration of different cytotoxic drugs via one single closed line-system by gravity or pressure with bottles and bags according to the SPC (Summary of product characteristics) of the drugs / solutions. Cyto-Set® is used for the application of cytotoxic agents in a closed system. The Cyto-Set® system reduces the probability of contamination of person and environment when preparing and applying cytotoxic drugs ensured by its technical components forming a closed system and the resulting workflow.Cyto-Set® InfusionIV administration set. Only for gravity infusion.Connection set for the administration of cytostatic drugs by gravity. Cyto-Set® Infusion is primed with a flushing solution (NaCl 0,9% or Glucose 5%). Cyto-Set® Mix or Cyto-Set® Line must be connected to the valve port of Cyto-Set® Infusion to administer the cytostatic drugs. One drug administration is always followed by a flushing step.Cyto-Set® can be used for all patients to whom cytotoxic drugs are prescribed in hospitals. Depending on the particular therapeutical concept and sensibility of the tumor to one or more cytotoxic agents the administration of these drugs represents an important role besides surgery and radiation therapy.

KIRO Oncology

KIRO Oncology helps to protect health care workers from the potential risks associated with manual drug admixture, especially from exposure to hazardous drugs. Additionally, the fully automated process optimizes the drug preparation output of the Hospital Pharmacy and enables digital control and tracing of complex workflows to help reducing medication errors. The benefits of B. Braun Safe Infusion Systems, combined with Kiro Grifols Automated Compounding Portfolio offer a complete solution for safe automated drug admixture and delivery.

Thank you for your registration.

check_circle

A responsible contact person will get in touch with you as soon as possible.

Your request could not be submitted. Please try again.

warning

References

1. Ford et al (2006): Study of Medication Errors on a Community Hospital Oncology Ward. Journal of Oncology Practice, 2006, 2 (4), 149-154. available at: https://ascopubs.org/doi/full/10.1200/jop.2006.2.4.149; accessed 05-06-2019.

2. Contreras Molina C, Garcia Morcillo, RM. (2021) SEGURIDAD DEL PACIENTE: NUEVAS TECNOLOGÍAS EN LA ADMINISTRACIÓN DE TRATAMIENTOS ONCOLÓGICOS. Poster P-110: 22 Congreso Nacional de Hospitales y Gestión Sanitaria. available at: https://www.22congresohospitales.org/pdf22/HOSPITALES_21/22-CONGRESO-HOSPITALES_compressed.pdf